Pfizer CEO Albert bourla sold 62% of its shares in the company on the same day that the pharmaceutical company announced the results of its Vaccine for COVID-19 judgment. Bourla sold $ 5.6 million in shares on Monday as part of a predetermined trading plan adopted on August 19. its …
Read More »Pfizer’s CEO withdrew 60% of its shares on the same day the company released the results of its COVID-19 vaccine test.
